Mode
Text Size
Log in / Sign up

ertugliflozin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ertugliflozin

6 trials tracked of ertugliflozin: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 87 citations.

6Trials tracked
4Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 3 4 Phase 2 1 Phase 1 1
  1. Phase 3 Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) Completed · 87 cited
  2. Phase 3 Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004) Completed · 45 cited
  3. Phase 3 Ertugliflozin for Functional Mitral Regurgitation Completed · 44 cited
  4. Phase 3 Effect of Ertugliflozin on Cardiac Function in Diabetes Completed · 9 cited
  5. Phase 2 ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure Completed
  6. Phase 1 Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009) Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.